UNSPSC 41202055: Rubeola (measles) virus serological reagents

In this classification, Rubeola (measles) virus serological reagents are devices used in test to identify specific Rubeola (measles) virus antibodies in serum. US FDA regulates Rubeola (measles) virus serological reagents under 21 CFR 866.3520 and under FDA product code GRJ.

UNSPSC 41202055 Rubeola (measles) virus serological reagents is a Commodity code, but the recent state and local opportunities tagged under it do not procure rubeola testing reagents. Instead, the code shows activity for HIV, syphilis, and general drug-testing reagents and laboratory services, revealing a mismatch between the code label and actual procurement scope. The opportunities span infectious-disease testing supplies (rapid HIV test kits, HIV/syphilis reagent kits for automated analyzers), drug-abuse screening supplies for correctional and probation services, and broader laboratory testing and specimen collection services. Issuing bodies include state health departments (Illinois Department of Public Health), county health services and probation/corrections departments (Collin County, Gwinnett County), city public health programs (City of Austin), and state criminal-justice agencies (Texas Department of Criminal Justice). Illinois Department of Public Health appears as a repeat buyer, executing emergency sole-source procurements for Abbott HIV and syphilis reagents to sustain CLIA-certified analyzer operations.

Recent activity concentrates in Illinois, Texas, and Georgia. The Illinois Department of Public Health issued an emergency procurement in May 2026 for Abbott HIV/Syphilis reagent kits totaling $38,079.50 and posted a change order in September 2026 for Abbott NG/NT sexually transmitted infection testing supplies, increasing contract cost by $375,000 to meet statewide testing demand. The City of Austin posted two rapid HIV test-kit solicitations (IFB 9100 AAM1023 and rebid IFB 9100 AAM1023REBID) in June and August 2026, seeking approximately 375 Abbott Determine test kits and 79 control kits annually. Collin County issued an RFP in September 2026 for offender specimen collection and drug testing services with approximately 25,031 annual tests across immunoassay and LC/MS/MS confirmation methodologies, estimated at $600,000 over two years. Gwinnett County, Georgia posted an RFP in September 2026 for drug testing supplies compatible with an existing analyzer system, though specifics on volumes and incumbent equipment were not detailed. The code shows no actual rubeola-specific procurement activity and warrants re-evaluation for correct categorization within serology and infectious-disease testing hierarchies.